| ||
| Mission Pharmacal Mission Pharmacal has distinguished itself through its commitment to ongoing clinical research and is on the verge of exciting new breakthroughs in the areas of osteoporosis and cardiovascular disease. |   |
MediGene Biopharmaceutical company dedicated to the discovery, development and commercialization of efficient and innovative therapeutics in the area of cancer and cardiac disease. |   | |
Parke-Davis A division of Warner-Lambert, researching, developing, manufacturing and marketing quality pharmaceuticals with a focus on medicines used to treat heart disease, diabetes, stroke, epilepsy and others. |   | |
Progen Industries Limited Design and development of unique carbohydrate pharmaceuticals to treat a variety of disease conditions, including cancer, cardiovascular disease and inflamations. |   | |
Schwarz Pharma Headquarters in Monheim, Germany, expertise in the areas of cardiovascular, gastro-intestinal and urologic medication |   | |
Diatide, Inc. Diatide (Nasdaq: DITI) is a specialty pharmaceutical company developing a line of disease-specific, diagnostic and therapeutic drugs for the treatment and diagnosis of life-threatening conditions such as cancer and cardiovascular disease. |   | |
IBEX Technologies A biopharmaceutical company developing enzyme-based therapeutics primarily for the treatment of cardiovascular disease. |   | |
Bayer Pharma: Cardiovascular Disease Provides information on cardiovascular products including Adalat, Aspirin Cardio, and Glucobay. |   | |
Nortran Pharmaceuticals Inc Nortran works in the cardiovascular, pain and respiratory areas with its lead programs in the area of cardiac arrhythmia drugs and acute unproductive cough. |   | |
Medco Research, Inc. Dedicated to being a leader in the global commercialization of cardiovascular medicines and adenosine-based products leading to superior growth in shareholder value. |   | |
Efroze Chemical Industries (Pvt) Limited Expanding the core business in the therapeutic classes of anti-infective, CNS, psychotropic, metabolic, alimentary tract, cardiovascular and diabetic drugs. |   | |
|